Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» US FDA staff focus on safety of Forest lung drug
US FDA staff focus on safety of Forest lung drug
US FDA staff focus on safety of Forest lung drug
Submitted by
admin
on February 21, 2012 - 9:00am
Source:
Reuters
News Tags:
FDA
Forest Labs
COPD
aclidinium bromide
Almirall
Headline:
US FDA staff focus on safety of Forest lung drug
Do Not Allow Advertisers to Use My Personal information
